Literature DB >> 24177664

[Androgenetic alopecia. Diagnosis and therapy- a current review].

U Blume-Peytavi1, A Vogt.   

Abstract

Androgenetic alopecia (AGA) is among the most frequent diagnoses in a hair clinic. Multiple studies prove that life quality is significantly impaired in affected individuals, independent of severity, age or gender. A thorough and standardized diagnostic approach to AGA in women, men and children is an essential step in developing a successful therapeutic concept. Treatment options range from topical and systemic medications to cosmetic products, nutricosmetics, hair transplantation and other aesthetic-corrective approaches. The physician and patient must decide together on the best suited individualized therapy, considering the expected results, practicality and compliance. Further interdisciplinary evaluation must be decided individually, as must the development of coping strategies and the decision to employ psychological support. A professional atmosphere and sensitive approach to an emotionally difficult situation help develop a trusting relationship between patient and physician, which in turn leads to greater satisfaction and compliance. The S1 guidelines for diagnosis and the S3 guidelines for treatment of AGA offer the treating physician important tools for the successful evidence-based management of patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24177664     DOI: 10.1007/s00105-013-2579-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  Male pattern baldness: classification and incidence.

Authors:  O T Norwood
Journal:  South Med J       Date:  1975-11       Impact factor: 0.954

2.  Prostanoid receptors in anagen human hair follicles.

Authors:  Laurent Colombe; Jean-François Michelet; Bruno Alain Bernard
Journal:  Exp Dermatol       Date:  2007-11-13       Impact factor: 3.960

3.  A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.

Authors:  Ulrike Blume-Peytavi; Kathrin Hillmann; Ekkehart Dietz; Douglas Canfield; Natalie Garcia Bartels
Journal:  J Am Acad Dermatol       Date:  2011-06-23       Impact factor: 11.527

4.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

Authors:  E Ludwig
Journal:  Br J Dermatol       Date:  1977-09       Impact factor: 9.302

5.  Finasteride-associated male infertility.

Authors:  Koji Chiba; Kohei Yamaguchi; Fuping Li; Makoto Ando; Masato Fujisawa
Journal:  Fertil Steril       Date:  2010-12-30       Impact factor: 7.329

6.  The prevalence and types of androgenetic alopecia in Korean men and women.

Authors:  J H Paik; J B Yoon; W Y Sim; B S Kim; N I Kim
Journal:  Br J Dermatol       Date:  2001-07       Impact factor: 9.302

7.  Prevalence of male and female pattern hair loss in Maryborough.

Authors:  Desmond C C Gan; Rodney D Sinclair
Journal:  J Investig Dermatol Symp Proc       Date:  2005-12

8.  Illness perceptions, coping and quality of life in patients with alopecia.

Authors:  T Cartwright; N Endean; A Porter
Journal:  Br J Dermatol       Date:  2009-01-20       Impact factor: 9.302

9.  Evidence for a polygenic contribution to androgenetic alopecia.

Authors:  S Heilmann; F F Brockschmidt; A M Hillmer; S Hanneken; S Eigelshoven; K U Ludwig; C Herold; E Mangold; T Becker; R Kruse; M Knapp; M M Nöthen
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

Review 10.  Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia.

Authors:  Ina M Hadshiew; Kerstin Foitzik; Petra C Arck; Ralf Paus
Journal:  J Invest Dermatol       Date:  2004-09       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.